How A, Dent PB, Liao SK, Denburg JA. Antineuronal antibodies in
neuropsychiatric systemic lupus erythematosus. Arthritis Rheum
1985;28:789–95.
Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA. Serum
lymphocytotoxic antibodies and neurocognitive function in systemic lupus
erythematosus. Ann Rheum Dis 1990;49:249–53.
Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB. The incidence
and prognosis of central nervous system disease in systemic lupus
erythematosus. J Rheumatol 1992;19:47–52.
Weiner SM, Klein R, Berg PA. A longitudinal study of autoantibodies
against central nervous system tissue and gangliosides in connective
tissue diseases. Rheumatol Int 2000;19:83–8.
The American College of Rheumatology nomenclature and case
definitions for neuropsychiatric lupus syndromes. Arthritis Rheum
1999;42:599–608.
Weiner SM, Otte A, Schumacher M, Klein R, Gutfleisch J, Brink I, et al.
Diagnosis and monitoring of central nervous system involvement in
systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann
Rheum Dis 2000;59:377–85.
Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric
systemic lupus erythematosus. Arthritis Rheum 1999;42:2026–38.
Abel T, Gladman DD, Urowitz MB. Neuropsychiatric lupus. J Rheumatol
1980;7:325–33.
Christenson RH, Behlmer P, Howard JF Jr, Winfield JB, Silverman LM.
Interpretation of cerebrospinal fluid protein assays in various neurologic
diseases. Clin Chem 1983;29:1028–30.
Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis
WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann
Intern Med 1992;116:488–98.
Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis:
prospective clinical and therapeutic experience with 85 patients for 21
years. Ann Intern Med 1983;98:76–85.
Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE.
Neurological involvement in Wegener's granulomatosis: an analysis of
324 consecutive patients at the Mayo Clinic. Ann Neurol 1993;33:4–9.
Drachman DA. Neurological complications of Wegener's
granulomatosis. Arch Neurol 1963;8:145–55.
Murphy JM, Gomez-Anson B, Gillard JH, Antoun NM, Cross J, Elliott JD,
et al. Wegener granulomatosis: MR imaging findings in brain and
meninges. Radiology 1999;213:794–9.
Jinnah HA, Dixon A, Brat DJ, Hellmann DB. Chronic meningitis with
cranial neuropathies in Wegener's granulomatosis. Case report and
review of the literature. Arthritis Rheum 1997;40:573–7.
Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the
central nervous system: diagnostic criteria and clinical approach. Cleve
Clin J Med 1992;59:293–306.
Wasserman BA, Stone JH, Hellmann DB, Pomper MG. Reliability of
normal findings on MR imaging for excluding the diagnosis of vasculitis
of the central nervous system. AJR Am J Roentgenol 2001;177:455–9.
Calabrese LH, Mallek JA. Primary angiitis of the central nervous system.
Report of 8 new cases, review of the literature, and proposal for
diagnostic criteria. Medicine (Baltimore) 1988;67:20–39.
Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB. CNS
vasculitis in autoimmune disease: MR imaging findings and correlation
with angiography. AJNR Am J Neuroradiol 1999;20:75–85.
Greenan TJ, Grossman RI, Goldberg HI. Cerebral vasculitis: MR
imaging and angiographic correlation. Radiology 1992;182:65–72.
Stone JH, Pomper MG, Roubenoff R, Miller TJ, Hellmann DB. Sensitivities
of noninvasive tests for central nervous system vasculitis: a comparison of
lumbar puncture, computed tomography, and magnetic resonance
imaging. J Rheumatol 1994;21:1277–82.
Serdaroglu P. Behçet's disease and the nervous system. J Neurol
1998;245:197–205.
Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of
neurological involvement in Behçet's disease: evaluation of 200 patients.
The Neuro-Behçet Study Group. Brain 1999;122:2171–82.
Trager J, Ward MM. Mortality and causes of death in systemic lupus
erythematosus. Curr Opin Rheumatol 2001;13:345–51.
Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre MH, et
al. Risk factors and prognostic influence of infection in a single cohort of
87 adults with systemic lupus erythematosus. Ann Rheum Dis
2001;60:1141–4.
Wang M, Tsai RT, Ou WC, Lin CK, Tsay GJ, Chang H, et al. Treatment
with cytotoxic immunosuppression agents increases urinary excretion of
JCV in patients with autoimmune disease. J Med Virol 2000;62:505–10.
Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal
leukoencephalopathy in patients with HIV infection. J Neurovirol
1998;4:59–68.
Arbusow V, Strupp M, Samtleben W, Hatz H, Bruckmann H, Brandt T.
Progressive multifocal leukoencephalopathy as a result of
immunosuppressive therapy. Dtsch Med Wochenschr 1999;124:653–6.
Ahmed F, Aziz T, Kaufman LD. Progressive multifocal
leukoencephalopathy in a patient with systemic lupus erythematosus. J
Rheumatol 1999;26:1609–12.
Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubinstein
LJ, et al. Isolation of virus related to SV40 from patients with progressive
multifocal leukoencephalopathy. N Engl J Med 1972;286:385–90.
Malas D, Weiss S. Progressive multifocal leukoencephalopathy and
cryptococcal meningitis with systemic lupus erythematosus and thymoma.
Ann Neurol 1977;1:188–91.
Newton P, Aldridge RD, Lessells AM, Best PV. Progressive multifocal
leukoencephalopathy complicating systemic lupus erythematosus. Arthritis
Rheum 1986;29:337–43.
